Service de néphrologie, CHU de Besançon
Besançon, 25000, France
NCT Number: NCT02116270
The aim of this study is to investigate the impact of renal function and dialysis techniques on the percentage of senescent T lymphocytes.
Looking for future studies?
Notify Me18 year–85 year
All sexes
Interventional
Not applicable
Besançon, 25000, France
The immunosenescence is a complex and profound remodeling of the immune system during life. It is mainly due to thymic involution and repeated antigenic stimulation. Kidney disease is associated with a decrease in adaptive immunity as evidenced by the decrease in vaccine response and increased susceptibility to infections, similar to those observed in the elderly population.
However, data on aging of the immune system in chronic kidney disease remains incomplete. Furthermore, the determinants of immunosenescence are not also not known. It is possible that "uremic" factors help explain the phenotypic and functional changes of lymphocytes, as antigenic stimuli associated with repeated bio-compatible materials used in dialysis contact.
The purpose of this study is to describe the phenotypes of the immune system of renal and analyze the determinants of these changes.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
3 tubes of 5 ml tubes and 4 of 7 ml for biological assays at t0.
Time frame: 6 months
The primary outcome measure is the percentage of CD 4/8+ CD 57+ CD 28- lymphocytes by flow cytometry. The technique used is a 6 colors surface labelling of T lymphocytes to study the T cell senescent population.
Time frame: 6 months
The telomerase activity of T lymphocytes is assessed by a method of Polymerase chain reaction (PCR)-ELISA.
Time frame: 6 months
This level is obtained by flow cytometry after permeabilization and labelling of Peripheral Blood Mononuclear Cells (PBMC).
Time frame: 6 months
RTE T cells will be defined by flow cytometry, according to co-expression of CD 4, CD 8,CD 31 and CD 45RA
Time frame: 6 months
TRECs study is based on a technique of quantitative PCR using DNA extracted from PBMC.
Time frame: 6 months
Study of telomere length is performed after extraction of DNA from isolated T cells. The length is determined by a quantitative PCR technique relative to a reference gene.
Looking for future studies?
Notify MeCentre Hospitalier Universitaire de Besancon
Other
Acronym: IRIS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05282732
Acute Kidney Injury, Acute Renal Failure
Hanover, Germany
View Trial DetailsNCT07058909
Acute Kidney Injury, Acute Renal Failure
Norfolk, Virginia, United States
View Trial DetailsNCT02644941
Chronic Disease, Disease Attributes
Phoenix, Arizona, United States
View Trial DetailsNCT06203977
Chronic Disease, Chronic Kidney Diseases
Edmonton, Alberta, Canada
View Trial Details